Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000843753 | SCV000985791 | benign | not provided | 2018-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001512893 | SCV001720390 | benign | Dowling-Degos disease 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001512893 | SCV002031607 | benign | Dowling-Degos disease 2 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000843753 | SCV005315031 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003975360 | SCV004790886 | benign | POFUT1-related disorder | 2019-05-02 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |